The reporter¿s meter was provided for investigation where it was tested using retention strips and controls.Testing results (qc range = 2.4 ¿ 3.6 inr): qc 1: 2.8 inr.Qc 2: 2.8 inr.Qc 3: 2.8 inr.The obtained qc values were in the allowed range of the used combination strip lot - qc lot.All measurements were without error messages.There were no errors observed during the investigation.The obtained qc values were observed in the meter memory without issues.There were no meter memory issues observed.The reported meter results of 3.8 inr and 5.2 inr were observed in the meter¿s result memory.The customer reported a missing test result from the meter memory.Product labeling states "the meter displays the result in about a minute.The meter automatically stores the result in memory so that you can easily recall results." handling errors were found in the error code report on (b)(6) 2022: error 4 - product labeling states "error: test strip unusable the test strip is unusable.Solution: turn the meter off, remove the test strip, and then re-insert it.If the error message reappears, discard the unusable test strip and use a new one." test strip error - product labeling states "error: test strip possible causes: ¿ a test strip was already inserted when the meter was turned on.¿ the meter timed out after you inserted the test strip.¿ the test strip is unusable.¿ the test strip is not a coaguchek xs pt test strip.Solution: remove the test strip.Then repeat the test with a new coaguchek xs pt test strip." on a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection. per product labeling: "coaguchek method uses human recombinant thromboplastin.Therefore, the comparability to tests using other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastin types.However, those higher differences between thromboplastins of different (rabbit, bovine) origin are not an issue specific for coaguchek assays.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared with several other (rabbit, bovine) laboratory methods." the investigation did not identify a product problem.The cause of the event could not be determined. initial reporter: occupation: patient/consumer.
|